Erbitux
From SNPedia
Erbitux is the brand name for cetuximab, a chimeric monoclonal antibody targeting (and thus inhibiting) the epidermal growth factor (EGFR) receptor. Cetuximab is most commonly used for the treatment of metastatic colorectal cancer and head and neck cancer. Wikipedia
SNPs influencing the efficacy of erbitux include:
